 |
|
trimetrexate glucuronate
A lipid soluble methotrexate derivative with potential antineoplastic activity. Trimetrexate glucuronate inhibits the enzyme dihydrofolate reductase, thereby preventing the synthesis of purine nucleotides and thymidylate, with subsequent inhibition of DNA and RNA synthesis. Trimetrexate glucuronate also exhibits antiviral activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | TMQ | | | | US brand name: | | Neutrexin | | | | Abbreviation: | | TMTX | | | | Chemical structure name: | | 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline mono-D-glucuronate | | |
|
|
